Tesamorelin

Tesamorelin (10mg) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) studied in research settings for its role in stimulating endogenous growth hormone secretion and evaluating downstream metabolic signaling pathways. In simple terms, researchers use Tesamorelin to better understand how targeted activation of the pituitary gland can influence growth hormone release patterns and related …

$50.00

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) studied in research settings for its role in stimulating endogenous growth hormone secretion and evaluating downstream metabolic signaling pathways. In simple terms, researchers use Tesamorelin to better understand how targeted activation of the pituitary gland can influence growth hormone release patterns and related metabolic processes in controlled laboratory models.

From a technical standpoint, Tesamorelin is a modified 44-amino-acid GHRH analog designed with a trans-3-hexenoic acid group that increases metabolic stability and resistance to enzymatic degradation. It acts as a selective agonist of the growth hormone-releasing hormone receptor (GHRH-R) in the anterior pituitary, promoting pulsatile growth hormone release. This activity is associated in research models with downstream IGF-1 signaling and modulation of lipid metabolism pathways.

In preclinical and clinical research contexts, Tesamorelin has been studied primarily for its effects on visceral adipose tissue metabolism, somatotropic axis regulation, and endocrine feedback mechanisms. It is often evaluated in metabolic research models focused on body composition, lipid mobilization pathways, and growth hormone axis responsiveness. Its effects are dependent on dosing, receptor sensitivity, and experimental conditions.

Tesamorelin is intended strictly for laboratory research purposes only and is not approved for human consumption, medical use, or diagnostic applications.

Key Research Areas

  • Growth hormone-releasing hormone (GHRH) receptor activation
  • Somatotropic (growth hormone) axis regulation
  • IGF-1 signaling pathway studies
  • Lipid metabolism and adipose tissue research models
  • Endocrine feedback loop and pituitary function studies

Chemical Information

  • Compound Name: Tesamorelin
  • Type: Synthetic GHRH analog peptide
  • Length: 44 amino acids
  • Modification: Trans-3-hexenoic acid group for stability
  • Mechanism: GHRH receptor agonist (pituitary stimulation)
  • Research Focus: Growth hormone axis and metabolic signaling pathways

Important Notice

This compound is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Proper handling and regulatory compliance are required by the purchaser.

Additional information